Viral Clearance Market Trends

Growth Drivers

• Growing Prevalence of Infectious Diseases to Boost the Market Growth

Based on the report provided by the World Health Organization (WHO), it was noticed that around 50,000 people die every day owing to some infectious diseases worldwide.

Infectious diseases are caused by various fungi, bacteria, and viruses and can be life-threatening sometimes. Diseases and disorders associated with infections are triggered by certain organisms that require early diagnosis so that they can be healed before spreading to multiple parts of the body. Viral clearance becomes useful since it removes viral contamination utilizing membranes or chromatography.

• Increasing Cases of Chronic Disease

According to the Centers for Disease Control and Prevention, it was noticed that 6 in 10 Americans have at least 1 chronic disease.

• Rising Demand for Viral Clearance in Non-Communicable Diseases

World Health Organization (WHO) stated that non-communicable diseases cause nearly 17.9 million people per year.

• Significant Increment in the Number of Viral Fevers

For instance, more than 150 million dengue virus infections are diagnosed every year across the globe.

Challenges

• Long-Lasting Development Procedure for Drug Discovery
• Lack of the Requisite Medical Workforce
• Requirement for Higher Initial Investment

The global viral clearance market is segmented and analyzed for demand and supply by end-user into CROs, pharmaceuticals, and biotechnology company, out of which, the CROs segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the rising investment in the R&D of new medical technology and medicine. For instance, the total spending on medicine across the world is evaluated at around USD 1 trillion in 2021.